Ibrutinib for therapy of steroid-refractory chronic graft vs. host disease: A multicenter real-world analysis.
Pidala JA, Kim J, Kalos D, Cutler CS, DeFilipp Z, Flowers ME, Hamilton BK, Chin KK, Rotta M, El Jurdi N, Hamadani M, Ahmed G, Kitko CL, Ponce DM, Sung AD, Tang H, Farhadfar N, Nemecek ER, Pusic I, Qayed M, Rangarajan HG, Hogan WJ, Etra AM, Jaglowski SM.
Pidala JA, et al. Among authors: ahmed g.
Blood Adv. 2024 Oct 25:bloodadvances.2024014374. doi: 10.1182/bloodadvances.2024014374. Online ahead of print.
Blood Adv. 2024.
PMID: 39454280